Stockreport

Dianthus CFO Sells 20,000 Shares for $903,600 After Massive Year-End Run [Yahoo! Finance]

Dianthus Therapeutics, Inc.  (DNTH) 
PDF This transaction represented 100% of CFO Ryan Savitz's direct equity holdings, resulting in a post-sale direct ownership of zero shares. The activity was executed ent [Read more]